UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diversification of TAM receptor tyrosine kinase function

Nature immunology, 2014-10, Vol.15 (10), p.920-928

2014

Volltextzugriff (PDF)

Genetic Dissection of TAM Receptor-Ligand Interaction in Retinal Pigment Epithelial Cell Phagocytosis

Neuron (Cambridge, Mass.), 2012-12, Vol.76 (6), p.1123-1132

2012

Volltextzugriff (PDF)

Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities

eLife, 2014-09, Vol.3

2014

Volltextzugriff (PDF)

Enveloped Viruses Disable Innate Immune Responses in Dendritic Cells by Direct Activation of TAM Receptors

Cell host & microbe, 2013-08, Vol.14 (2), p.136-147

2013

Volltextzugriff (PDF)

The precise sequence of FGF receptor autophosphorylation is kinetically driven and is disrupted by oncogenic mutations

Science signaling, 2009-02, Vol.2 (58), p.ra6

2009

Volltextzugriff (PDF)

Autophosphorylation of FGFR1 Kinase Is Mediated by a Sequential and Precisely Ordered Reaction

Molecular cell, 2006-03, Vol.21 (5), p.711-717

2006

Volltextzugriff (PDF)

TAM receptors regulate multiple features of microglial physiology

Nature (London), 2016-04, Vol.532 (7598), p.240-244

2016

Volltextzugriff (PDF)

Mutations in different components of FGF signaling in LADD syndrome

Nature genetics, 2006-04, Vol.38 (4), p.414-417

2006

Volltextzugriff (PDF)

Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor

Cancer research (Chicago, Ill.), 2019-04, Vol.79 (8), p.1996-2008

2019

Volltextzugriff (PDF)

Lacrimo-Auriculo-Dento-Digital Syndrome Is Caused by Reduced Activity of the Fibroblast Growth Factor 10 (FGF10)-FGF Receptor 2 Signaling Pathway

Molecular and Cellular Biology, 2007-10, Vol.27 (19), p.6903-6912

2007

Volltextzugriff (PDF)

The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity

Nature medicine, 2015-12, Vol.21 (12), p.1464-1472

2015

Volltextzugriff (PDF)

Structural basis for reduced FGFR2 activity in LADD syndrome: Implications for FGFR autoinhibition and activation

Proceedings of the National Academy of Sciences - PNAS, 2007-12, Vol.104 (50), p.19802-19807

2007

Volltextzugriff (PDF)

A ligand for ALK

Science signaling, 2015-01, Vol.8 (360), p.fs2

2015

Volltextzugriff (PDF)

Abstract 2672: ERAS-007 is a selective ERK1/2 inhibitor with preclinical activity across RAS/MAPK pathway-driven CRC models

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2672-2672

2022

Volltextzugriff (PDF)

Abstract 335: In situ protein complexes as a measure of AXL signaling and inhibitor response in cell line models of lung cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.335-335

2017

Volltextzugriff (PDF)

Abstract 4698: Immuno-oncological efficacy of RXDX-106, a novel, selective and potent small molecule TAM (TYRO3, AXL, MER) inhibitor

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4698-4698

2017

Volltextzugriff (PDF)

Abstract 4191: RXDX-106, a novel, selective and potent small molecule TAM (TYRO3, AXL, MER) inhibitor, demonstrates efficacy in TAM-driven tumors

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4191-4191

2017

Volltextzugriff (PDF)

Abstract 3771: Mechanistic and pharmacodynamic characterization of the immuno-oncological activity of RXDX-106, a novel TYRO3, AXL, and MER (TAM) inhibitor in clinical development

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3771-3771

2018

Volltextzugriff (PDF)

Abstract 2669: ERAS-007 (ERK inhibitor) + ERAS-601 (SHP2 inhibitor) exhibit nonclinical combination activity across KRAS mutated NSCLC, CRC, and PDAC tumor models

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2669-2669

2022

Volltextzugriff (PDF)

Abstract 2675: Discovery of potent CNS-penetrant covalent KRAS G12C inhibitors

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2675-2675

2022

Volltextzugriff (PDF)

Abstract A37: Immuno-oncological efficacy of RXDX-106, a novel TAM (TYRO3, AXL, MER) family small-molecule kinase inhibitor

Cancer immunology research, 2018-09, Vol.6 (9_Supplement), p.A37-A37

2018

Volltextzugriff (PDF)

Erratum: Mutations in different components of FGF signaling in LADD syndrome

Nature genetics, 2006-04, Vol.38 (4), p.495-495

2006

Volltextzugriff (PDF)

Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial

JAMA dermatology (Chicago, Ill.), 2018-02, Vol.154 (2), p.167

2018

Volltextzugriff (PDF)

Beneficial Effects of Prebiotic Saccharomyces cerevisiae Mannan on Allergic Asthma Mouse Models

Journal of Immunology Research, 2017-01, Vol.2017 (2017), p.1-10

2017

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(27)

Publikationsform

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(21)
Humans
(14)
Animals
(8)
Female
(7)
Male
(7)
Receptor Protein-Tyrosine Kinases - Metabolism
(7)
C-Mer Tyrosine Kinase
(6)
Mice
(6)
Proto-Oncogene Proteins - Metabolism
(6)
Apoptosis
(5)
Cell Biology
(5)
Neurosciences & Neurology
(5)
Signal Transduction
(5)
Surgery
(5)
Biochemistry & Molecular Biology
(4)
Clinical Neurology
(4)
Intercellular Signaling Peptides And Proteins - Metabolism
(4)
Ligands
(4)
Mice, Inbred C57bl
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diversification of TAM receptor tyrosine kinase function

Genetic Dissection of TAM Receptor-Ligand Interaction in Retinal Pigment Epithelial Cell Phagocytosis

Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities

Enveloped Viruses Disable Innate Immune Responses in Dendritic Cells by Direct Activation of TAM Receptors

The precise sequence of FGF receptor autophosphorylation is kinetically driven and is disrupted by oncogenic mutations

Autophosphorylation of FGFR1 Kinase Is Mediated by a Sequential and Precisely Ordered Reaction

TAM receptors regulate multiple features of microglial physiology

Mutations in different components of FGF signaling in LADD syndrome

Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor

Lacrimo-Auriculo-Dento-Digital Syndrome Is Caused by Reduced Activity of the Fibroblast Growth Factor 10 (FGF10)-FGF Receptor 2 Signaling Pathway

The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity

Structural basis for reduced FGFR2 activity in LADD syndrome: Implications for FGFR autoinhibition and activation

A ligand for ALK

Abstract 2672: ERAS-007 is a selective ERK1/2 inhibitor with preclinical activity across RAS/MAPK pathway-driven CRC models

Abstract 335: In situ protein complexes as a measure of AXL signaling and inhibitor response in cell line models of lung cancer

Abstract 4698: Immuno-oncological efficacy of RXDX-106, a novel, selective and potent small molecule TAM (TYRO3, AXL, MER) inhibitor

Abstract 4191: RXDX-106, a novel, selective and potent small molecule TAM (TYRO3, AXL, MER) inhibitor, demonstrates efficacy in TAM-driven tumors

Abstract 3771: Mechanistic and pharmacodynamic characterization of the immuno-oncological activity of RXDX-106, a novel TYRO3, AXL, and MER (TAM) inhibitor in clinical development

Abstract 2669: ERAS-007 (ERK inhibitor) + ERAS-601 (SHP2 inhibitor) exhibit nonclinical combination activity across KRAS mutated NSCLC, CRC, and PDAC tumor models

Abstract 2675: Discovery of potent CNS-penetrant covalent KRAS G12C inhibitors

Abstract A37: Immuno-oncological efficacy of RXDX-106, a novel TAM (TYRO3, AXL, MER) family small-molecule kinase inhibitor

Erratum: Mutations in different components of FGF signaling in LADD syndrome

Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial

Association of Patient Belief About Success of Antibiotics for Appendicitis and Outcomes: A Secondary Analysis of the CODA Randomized Clinical Trial

Beneficial Effects of Prebiotic Saccharomyces cerevisiae Mannan on Allergic Asthma Mouse Models

Suchergebnisse filtern